Celltrion
068270.KS
#888
Rank
C$38.21 B
Marketcap
C$174.96
Share price
-2.31%
Change (1 day)
16.06%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2025 (TTM): C$2.64

According to Celltrion 's latest financial reports the company's current EPS (TTM) is C$2.62. an increase over its 2024 EPS that were of C$1.71.

EPS history for Celltrion from 2007 to 2025

Annual EPS

Year EPS Change
2025C$4.50163.66%
2024C$1.71-53.73%
2023C$3.69-2.08%
2022C$3.77-11.72%
2021C$4.272.03%
2020C$4.1882.8%
2019C$2.2918.31%
2018C$1.93-36.33%
2017C$3.04161.25%
2016C$1.162.86%
2015C$1.1317.84%
2014C$0.965.87%
2013C$0.91-70.85%
2012C$3.11134.09%
2011C$1.3343.59%
2010C$0.9274.49%
2009C$0.53317.8%
2008C$0.13-71.7%
2007C$0.45